prescription-access
(3)
Forus
Forus is a New York-based healthtech company (formerly Tandem Technology, Inc.) that runs an AI-powered network connecting doctors, pharmacies, payers, and biopharma to get prescribed medications to patients faster. Its software embeds in physician workflows and automates the administrative steps between a clinical decision and a patient starting treatment - prior authorization, benefit verification, financial assistance, and pharmacy routing. Free for doctors and patients, Forus earns revenue through pharmaceutical partnerships. Founded in 2023 by former Oscar Health product leader Sahir Jaggi, the company reached a reported $1 billion valuation in May 2026 with backing from Thrive Capital, General Catalyst, and Accel.
Sahir Jaggi
Sahir Jaggi is the founder and CEO of Forus, an AI-powered network (formerly known as Tandem) that automates the paperwork sitting between a doctor's prescription and a patient actually getting the drug. Forus emerged from stealth in May 2026 with $160M in funding at a $1B valuation from Thrive Capital, General Catalyst, and Accel. Before Forus, Jaggi spent six years as a product leader at Oscar Health after studying biomedical engineering and computer science at Columbia.
PARx Solutions
PARx Solutions is a Burlington, Massachusetts healthcare technology and services company that untangles one of medicine's most frustrating chores: prior authorization. Its Prior Authorization Support System (PASS) pairs a secure web portal with a call center of healthcare and reimbursement specialists who handle the paperwork and back-and-forth with health plans on a prescriber's behalf. Because the service is sponsored by drug manufacturers, it is free to physician offices and pharmacies, and it helps patients actually get the medications their doctors prescribed rather than abandoning treatment in the administrative maze.